What To Expect From Kura Oncology Inc (KURA) Q3 2025 Earnings
This article first appeared on GuruFocus.
Kura Oncology Inc (NASDAQ:KURA) is set to release its Q3 2025 earnings on Nov 4, 2025. The consensus estimate for Q3 2025 revenue is $41.26 million, and the earnings are expected to come in at -$0.85 per share. The full year 2025's revenue is expected to be $89.08 million, and the earnings are expected to be -$2.40 per share. More detailed estimate data can be found on the Forecast page.
Warning! GuruFocus has detected 3 Warning Signs with KURA.
Is KURA fairly valued? Test your thesis with our free DCF calculator.
Over the past 90 days, revenue estimates for Kura Oncology Inc (NASDAQ:KURA) have declined from $108.07 million to $89.08 million for the full year 2025 and from $229.59 million to $215.21 million for 2026. Similarly, earnings estimates have declined from -$2.14 per share to -$2.40 per share for the full year 2025 and from -$2.27 per share to -$2.33 per share for 2026.
In the previous quarter ending on June 30, 2025, Kura Oncology Inc's (NASDAQ:KURA) actual revenue was $15.29 million, which missed analysts' revenue expectations of $36.66 million by -58.30%. Kura Oncology Inc's (NASDAQ:KURA) actual earnings were -$0.75 per share, which missed analysts' earnings expectations of -$0.43 per share by -75.64%. After releasing the results, Kura Oncology Inc (NASDAQ:KURA) was down by -7.05% in one day.
Based on the one-year price targets offered by 11 analysts, the average target price for Kura Oncology Inc (NASDAQ:KURA) is $27, with a high estimate of $40 and a low estimate of $11. The average target implies an upside of 163.16% from the current price of $10.26.
Based on GuruFocus estimates, the estimated GF Value for Kura Oncology Inc (NASDAQ:KURA) in one year is $0, suggesting a downside of -100% from the current price of $10.26.
Based on the consensus recommendation from 15 brokerage firms, Kura Oncology Inc's (NASDAQ:KURA) average brokerage recommendation is currently 1.9, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.